Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Japan Lifeline Co., Ltd.
  6. Summary
    7575   JP3754500001

JAPAN LIFELINE CO., LTD.

(7575)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Japan Exchange
01/24/2022 01/25/2022 01/26/2022 01/27/2022 01/28/2022 Date
1091(c) 1066(c) 1050(c) 1028(c) 1046(c) Last
118 300 174 300 164 100 239 200 213 400 Volume
+1.77% -2.29% -1.50% -2.10% +1.75% Change
More quotes
Estimated financial data (e)
Sales 2022 52 682 M 457 M 457 M
Net income 2022 7 757 M 67,3 M 67,3 M
Net cash position 2022 7 846 M 68,1 M 68,1 M
P/E ratio 2022 11,0x
Yield 2022 3,63%
Sales 2023 55 394 M 481 M 481 M
Net income 2023 8 318 M 72,2 M 72,2 M
Net cash position 2023 11 987 M 104 M 104 M
P/E ratio 2023 10,3x
Yield 2023 3,90%
Capitalization 84 120 M 730 M 730 M
EV / Sales 2022 1,45x
EV / Sales 2023 1,30x
Nbr of Employees 1 167
Free-Float -
More Financials
Company
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac... 
More about the company
Ratings of Japan Lifeline Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about JAPAN LIFELINE CO., LTD.
01:16aJAPAN LIFELINE : Summary Report of Consolidated Financial Results for the Nine Months Ende..
PU
01:16aJAPAN LIFELINE : Notice on Changes in Organizations and Personnel
PU
2021JAPAN LIFELINE : Notice on Changes in Organizations and Personnel
PU
2021Japan Lifeline Co., Ltd. Announces Changes in Organizations and Personnel
CI
2021Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2022
CI
2021Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2022
CI
2021JAPAN LIFELINE : Notice on Acquisition of Shares of Sub-subsidiary
PU
2021JAPAN LIFELINE : Notice on Board Resolution on Selection for TSE's New Prime Market Segmen..
PU
2021Japan Lifeline Co., Ltd. Announces Changes in Organizations, Effective on October 1, 20..
CI
2021Japan Lifeline Co., Ltd. Announces Changes in Personnel, Effective on October 1, 2021
CI
2021JAPAN LIFELINE : Summary Report of Consolidated Financial Results for the Three Months End..
PU
2021Japan Lifeline Co., Ltd. Reports Consolidated Earnings Results for the First Quarter En..
CI
2021Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Six Months Ending September..
CI
2021Japan Lifeline Co., Ltd. Provides Year End Cash Dividend Guidance for the Year Ending M..
CI
2021JAPAN LIFELINE : Announcement on Initiation of Clinical Trial for Jointly Developed Produc..
PU
More news
News in other languages on JAPAN LIFELINE CO., LTD.
2021Japan Lifeline Co., Ltd. fournit des indications sur le dividende pour l'année se termi..
2021Japan Lifeline Co., Ltd. fournit des prévisions de résultats pour l'année se terminant ..
2021Japan Lifeline Co., Ltd. fournit des prévisions de bénéfices pour le semestre se termin..
2021Japan Lifeline Co., Ltd. fournit des indications sur le dividende en espèces de fin d'a..
2021Japan Lifeline Co., Ltd. fournit des prévisions de bénéfices pour les six mois et l'ann..
More news
Chart JAPAN LIFELINE CO., LTD.
Duration : Period :
Japan Lifeline Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JAPAN LIFELINE CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Last Close Price 1 046,00 JPY
Average target price 1 450,00 JPY
Spread / Average Target 38,6%
EPS Revisions
Managers and Directors
Keisuke Suzuki President & Representative Director
Takeshi Egawa Manager-Accounting & Finance
Yumiko Hoshiba Manager-General Affairs
Kenji Yamada Executive Officer & General Manager-Administration
Fumihiro Sasaki Independent Outside Director
Sector and Competitors